Cardiovascular Reprogramming and Regeneration Conference 2026
Join leading experts, researchers, and clinicians at the 2nd CRR 2026 Conference in Boston, where we will explore the latest advances in cardiomyocyte reprogramming, vascular regeneration, cardiac organoids, and bioengineering. This one-day event features distinguished speakers, interactive sessions, and networking opportunities, fostering collaboration and innovation in cardiovascular science.
July 11, 2026
The Colonnade Hotel
►120 Huntington Ave, Boston, MA 02116
Featured Speakers
Hee Cheol Cho, PhD
Johns Hopkins University
Li Qian, PhD
University of North Carolina-Chapel Hill
Joseph C. Wu, MD, PhD
Stanford University
Kyoung-Han Kim, PhD
University of Ottawa
Daniel J. Garry, MD, PhD
University of Minnesota
Shahin Rafii, MD
Cornell University
Young-sup Yoon, MD, PhD
Emory University/Georgia Institute of Technology/Yonsei University
Changwon Park, PhD
Louisiana State University Health Shreveport
Hesham A. Sadek, MD, PhD
University of Arizona
Sean M. Wu, MD, PhD
Stanford University
Rebecca D. Levit, MD
Emory University/Georgia Institute of Technology
Chul-Hwan Lee, PhD
Seoul National University, Korea
Jay Zhang, MD, PhD
University of Alabama Birmingham
Jinah Jang, PhD
Pohang University of Science and Technology, Korea
Youngkeun Ahn, MD, PhD
Chonnam National University, Korea
Hyun-Ji Park, PhD
Ajou University, Korea
Session Chairs
W. Robert Taylor, MD, PhD
Emory University
Young-sup Yoon, MD, PhD
Emory University
Sang-Ho Lee, PhD
Emory University
Il-man Kim, PhD
Indiana University
John Calvert, PhD
Emory University
Conference Agenda
Program Details
| Session I | Cardiomyocyte Reprogramming & Regeneration |
| 08:30-08:55 | Hee Cheol Cho, PhD Tissue level reprogramming for cardiac pacing |
| 08:55-09:20 | Li Qian, PhD Rewriting Cardiac Cell Fate for Heart Repair |
| 09:20-09:45 | Joseph C. Wu, MD, PhD New Approach Methodologies (NAMs) and Clinical Trial-in-a-Dish (CTiD) in Cardiovascular Medicine |
| 09:45-10:10 | Jay Zhang, MD, PhD FoxM1 promotes cardiomyocyte regeneration in mammalian hearts with post-infarction LV remodeling |
| Session II | Vascular Reprogramming & Regeneration |
| 10:30-10:55 | Daniel J. Garry, MD, PhD ETV2 mediated reprogramming to the vascular lineage |
| 10:55-11:20 | Shahin Rafii, MD Molecular determinants of adaptive cardiac microvascular endothelial cells in health and disease |
| 11:20-11:45 | Young-sup Yoon, MD, PhD Vascular regeneration with stem cells and reprogrammed cells |
| 11:45-12:10 | Changwon Park, PhD ETV2 and vascular regeneration |
| Session III | Cardiac Biology and Organoids |
| 13:30-13:55 | Hesham A. Sadek, MD, PhD Heart Regeneration and Mito-Nuclear Communication |
| 13:55-14:20 | Sean M. Wu, MD, PhD Leveraging Developmental Mechanisms to Enhance Cardiac Regeneration |
| 14:20-14:45 | Rebecca D. Levit, MD Minimally invasive delivery hydrogel-assisted cardiac gene therapy |
| 14:45-15:10 | Chul-Hwan Lee, PhD EZH1 Safeguards Cardiomyocyte Identity and Prevents Fibrotic Activation |
| Session IV | Cardiac Biology & Bioengineering |
| 15:30-15:55 | Kyoung-Han Kim, PhD Establishing Ventricular Wall Heterogeneity |
| 15:55-16:20 | Jinah Jang, PhD Bioprinting-Assisted Tissue Engineering Toward Next-Generation Therapeutics |
| 16:20-16:45 | Youngkeun Ahn, MD, PhD Macrophage Plasticity in Cardiac Fibrosis |
| 16:45-17:10 | Hyun-Ji Park, PhD Causal Single-Cell Multiomics Identifies M2c Macrophage-Mgl2 Axis as a Key Regulator of Postnatal Pulmonary Artery Remodeling |